SOLICITATION NOTICE
R -- VRC Regulatory Operations Support Services - Package #1
- Notice Date
- 9/18/2019
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541690
— Other Scientific and Technical Consulting Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 5601 Fishers Lane, 3rd Floor MSC 9822, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- NIAID-RFQ19-1975722
- Archive Date
- 10/9/2019
- Point of Contact
- Julie Yun, Phone: 2406273734
- E-Mail Address
-
julie.yun@nih.gov
(julie.yun@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- NIAID-RFQ19-1975722 - Statement of Work (SOW) Wage Determinaton NIAID-RFQ19-1975722 - Quote Template with Proposed Hours NIAID-RFQ19-1975722 - FAR Provisions and Clauses NIAID-RFQ19-1975722 - Additional FAR Provisions and Clauses HHS Subcontracting Plan Template Title: VRC Regulatory Operations Support Services This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. Submit quotes on NIAID-RFQ19-1975722. This solicitation is a request for quotes (RFQ). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2019-05, effective August 13, 2019. The associated North American Industry Classification System (NAICS) code for this procurement is 541690, Other Scientific and Technical Consulting Services with a small business size standard of $16,500,000. Background and Laboratory Needs: The Vaccine Research (VRC) develops investigational vaccine and monoclonal antibody products with prophylactic and therapeutic indications for a number of pathogens including filovirus, flavivirus, influenza and HIV. Clinical development of these products is managed by the VRC's Clinical Trials Program (CTP) and is conducted in the intramural clinic at the NIH Clinical Center and/or via external collaborations and partnerships, both domestic and international. These clinical trials yield valuable data pertaining to the safety, tolerability, and efficacy of VRC products in supports VRC's translational research mission. The VRC requires regulatory operations support services for Investigational New Drug (IND) Applications sponsored by the VRC. Regulatory activities will ensure IND Sponsor compliance with applicable federal regulations and guidelines, ensure research is conducted ethically, human subjects are protected, and data integrity is preserved. See Statement of Work attachment for requirement. Quotes shall include pricing for loaded labor rates for a period of performance of one (1) base year, with an additional three (3) option years. FOB Point Shall be Destination: Vaccine Research Center 40 Convent Drive Bethesda, MD 20814 Anticipated Period of Performance: September 26, 2019 to September 25, 2020, with Three (3) Option Years The Government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. NIAID will evaluate quotes to determine the most advantageous to the government. NIAID will make that determination based on technical acceptability and price. The Government's objective is to obtain the highest technical solution considered necessary to achieve the project objectives with a reasonable price. NIAID will evaluate for price only those quotes which are rated technically acceptable. In the event quotes are evaluated as technically equal, price will become a major consideration in selecting the successful Vendor. [Applicable to Large Businesses Only] NIAID highly encourages small business participation. FAR 52.219-9 requires a small business subcontracting plan in order to be eligible for contract award if subcontracting possibilities exist. This requirement does not apply to small business or small disadvantaged business responders. The HHS Subcontracting Plan template attachment is provided as an outline that meets the minimal requirements of Section 8(d) of the Small Business Act, as amended, and implemented by the FAR Subpart 19.7. This outline is not intended to replace any existing corporate master plan, which is more extensive. Assistance is available for locating small and small disadvantaged business sources by contacting NIAID's Small Business Specialist. For contact information, please send an inquiry to Julie Yun at julie.yun@nih.gov. FAR provisions and clauses are attached. Quoter must also include the following provision in their quote and check the appropriate response: 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) (a) Definitions. "Inverted domestic corporation" and "subsidiary" have the meaning given in the clause of this contract entitled Prohibition on Contracting with Inverted Domestic Corporations (52.209-10). (b) Government agencies are not permitted to use appropriated (or otherwise made available) funds for contracts with either an inverted domestic corporation, or a subsidiary of an inverted domestic corporation, unless the exception at 9.108-2(b) applies or the requirement is waived in accordance with the procedures at 9.108-4. (c) Representation. By submission of its offer, the offeror represents that- (check one) ____(1) It is not an inverted domestic corporation: and ____(2) It is not a subsidiary of an inverted domestic corporation By submission of a quote, the quoter acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). This is an open-market combined synopsis/solicitation for services as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes should include a statement regarding the terms and conditions herein as follows: "The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition." OR "The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:" (Quoter shall list exception(s) and rationale for the exception(s).) Offers shall be e-mailed to julie.yun@nih.gov Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). SPECIAL NOTICE TO OFFERORS Offerors are advised that the Government may share your information with non-government personnel who are assisting with the evaluation of quotes. The exclusive responsibility for source selection will reside with the Government. By submitting your offer, you will be consenting to disclosure of your offer to non-government personnel for purposes of evaluation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/AMOB/NIAID-RFQ19-1975722/listing.html)
- Place of Performance
- Address: 40 Convent Drive, Bethesda, Maryland, 20814, United States
- Zip Code: 20814
- Zip Code: 20814
- Record
- SN05450125-W 20190920/190918231248-9a97a7b32738c072a4a7fb218562c9e2 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |